If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:104987-11-3
Source:India
Qualifications:USDMF/CEP/-/-/-
Name | Tacrolimus |
---|---|
Chinese name | 他克莫司 |
Cas Number | 104987-11-3 |
Source | India |
Qualifications | USDMF/CEP/-/-/- |
As a powerful new immunosuppressant, tacrolimus mainly inhibits the release of interleukin-2 (L-2) to fully inhibit the effect of T lymphocytes, which is 100 times stronger than cyclosporine (CsA). As a first-line drug for liver and kidney transplantation, tacrolimus has been marketed in 14 countries including Japan and the United States. Clinical experiments show that it has a good effect in transplantation of heart, lung, intestine, bone marrow, etc. At the same time, tacrolimus also plays an active role in the treatment of atopic dermatitis (AD), systemic lupus erythematosus (SLE), autoimmune eye disease and other autoimmune diseases.
Hot Tags: tacrolimus api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Dimethyl Fumarate API, Tetrabenazine API, Ticagrelor API, Pabxilib API, Bosentan API, Valganciclovir Hydrochloride API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China